Vericel Corp Ord Stock Net Income
| VCEL Stock | USD 36.20 0.38 1.04% |
As of the 28th of January, Vericel Corp has the Semi Deviation of 2.44, coefficient of variation of 6116.62, and Risk Adjusted Performance of 0.0195. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Vericel Corp Ord, as well as the relationship between them. Please validate Vericel Corp Ord jensen alpha, potential upside, as well as the relationship between the Potential Upside and skewness to decide if Vericel Corp is priced more or less accurately, providing market reflects its prevalent price of 36.2 per share. Given that Vericel Corp Ord has jensen alpha of (0.06), we advise you to double-check Vericel Corp Ord's current market performance to make sure the company can sustain itself at a future point.
Vericel Corp Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 7.0062 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Income | 11.9 M | 12.5 M | |
| Net Income From Continuing Ops | 11.9 M | 12.5 M | |
| Net Loss | -19.2 M | -20.2 M | |
| Net Income Per Share | 0.19 | 0.20 | |
| Net Income Per E B T | 0.89 | 0.82 |
Vericel | Net Income | Build AI portfolio with Vericel Stock |
Latest Vericel Corp's Net Income Growth Pattern
Below is the plot of the Net Income of Vericel Corp Ord over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Vericel Corp Ord financial statement analysis. It represents the amount of money remaining after all of Vericel Corp Ord operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Vericel Corp's Net Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Vericel Corp's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 10.36 M | 10 Years Trend |
|
Net Income |
| Timeline |
Vericel Net Income Regression Statistics
| Arithmetic Mean | (9,134,446) | |
| Coefficient Of Variation | (135.29) | |
| Mean Deviation | 9,741,828 | |
| Median | (9,900,000) | |
| Standard Deviation | 12,357,871 | |
| Sample Variance | 152.7T | |
| Range | 42M | |
| R-Value | 0.79 | |
| Mean Square Error | 60T | |
| R-Squared | 0.63 | |
| Significance | 0.0001 | |
| Slope | 1,944,939 | |
| Total Sum of Squares | 2443.5T |
Vericel Net Income History
Other Fundumenentals of Vericel Corp Ord
| Net Income From Continuing Ops | ||
| Net Income Applicable To Common Shares | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Vericel Corp Net Income component correlations
Vericel Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Vericel Corp is extremely important. It helps to project a fair market value of Vericel Stock properly, considering its historical fundamentals such as Net Income. Since Vericel Corp's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Vericel Corp's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Vericel Corp's interrelated accounts and indicators.
Click cells to compare fundamentals
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vericel Corp. If investors know Vericel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vericel Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.476 | Earnings Share 0.26 | Revenue Per Share | Quarterly Revenue Growth 0.166 | Return On Assets |
The market value of Vericel Corp Ord is measured differently than its book value, which is the value of Vericel that is recorded on the company's balance sheet. Investors also form their own opinion of Vericel Corp's value that differs from its market value or its book value, called intrinsic value, which is Vericel Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vericel Corp's market value can be influenced by many factors that don't directly affect Vericel Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vericel Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vericel Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vericel Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Vericel Corp 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Vericel Corp's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Vericel Corp.
| 10/30/2025 |
| 01/28/2026 |
If you would invest 0.00 in Vericel Corp on October 30, 2025 and sell it all today you would earn a total of 0.00 from holding Vericel Corp Ord or generate 0.0% return on investment in Vericel Corp over 90 days. Vericel Corp is related to or competes with Uniqure NV, Structure Therapeutics, Edgewise Therapeutics, Viridian Therapeutics, Aurinia Pharmaceuticals, Nuvation Bio, and MannKind Corp. Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, an... More
Vericel Corp Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Vericel Corp's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Vericel Corp Ord upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.52 | |||
| Information Ratio | (0.01) | |||
| Maximum Drawdown | 14.74 | |||
| Value At Risk | (5.10) | |||
| Potential Upside | 4.71 |
Vericel Corp Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Vericel Corp's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Vericel Corp's standard deviation. In reality, there are many statistical measures that can use Vericel Corp historical prices to predict the future Vericel Corp's volatility.| Risk Adjusted Performance | 0.0195 | |||
| Jensen Alpha | (0.06) | |||
| Total Risk Alpha | (0.24) | |||
| Sortino Ratio | (0.01) | |||
| Treynor Ratio | 0.0272 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Vericel Corp's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Vericel Corp January 28, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0195 | |||
| Market Risk Adjusted Performance | 0.0372 | |||
| Mean Deviation | 2.23 | |||
| Semi Deviation | 2.44 | |||
| Downside Deviation | 2.52 | |||
| Coefficient Of Variation | 6116.62 | |||
| Standard Deviation | 2.92 | |||
| Variance | 8.51 | |||
| Information Ratio | (0.01) | |||
| Jensen Alpha | (0.06) | |||
| Total Risk Alpha | (0.24) | |||
| Sortino Ratio | (0.01) | |||
| Treynor Ratio | 0.0272 | |||
| Maximum Drawdown | 14.74 | |||
| Value At Risk | (5.10) | |||
| Potential Upside | 4.71 | |||
| Downside Variance | 6.37 | |||
| Semi Variance | 5.98 | |||
| Expected Short fall | (2.58) | |||
| Skewness | 0.5868 | |||
| Kurtosis | 0.6269 |
Vericel Corp Ord Backtested Returns
As of now, Vericel Stock is very steady. Vericel Corp Ord owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0406, which indicates the firm had a 0.0406 % return per unit of risk over the last 3 months. We have found twenty-seven technical indicators for Vericel Corp Ord, which you can use to evaluate the volatility of the company. Please validate Vericel Corp's Risk Adjusted Performance of 0.0195, coefficient of variation of 6116.62, and Semi Deviation of 2.44 to confirm if the risk estimate we provide is consistent with the expected return of 0.12%. Vericel Corp has a performance score of 3 on a scale of 0 to 100. The entity has a beta of 1.39, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Vericel Corp will likely underperform. Vericel Corp Ord right now has a risk of 2.95%. Please validate Vericel Corp potential upside, as well as the relationship between the skewness and day typical price , to decide if Vericel Corp will be following its existing price patterns.
Auto-correlation | 0.16 |
Very weak predictability
Vericel Corp Ord has very weak predictability. Overlapping area represents the amount of predictability between Vericel Corp time series from 30th of October 2025 to 14th of December 2025 and 14th of December 2025 to 28th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Vericel Corp Ord price movement. The serial correlation of 0.16 indicates that over 16.0% of current Vericel Corp price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.16 | |
| Spearman Rank Test | 0.13 | |
| Residual Average | 0.0 | |
| Price Variance | 1.61 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Vericel Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Vericel Corp Ord reported net income of 10.36 M. This is 96.96% lower than that of the Biotechnology sector and 85.21% lower than that of the Health Care industry. The net income for all United States stocks is 98.19% higher than that of the company.
Vericel Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Vericel Corp's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Vericel Corp could also be used in its relative valuation, which is a method of valuing Vericel Corp by comparing valuation metrics of similar companies.Vericel Corp is currently under evaluation in net income category among its peers.
Vericel Corp ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Vericel Corp's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Vericel Corp's managers, analysts, and investors.Environmental | Governance | Social |
Vericel Corp Institutional Holders
Institutional Holdings refers to the ownership stake in Vericel Corp that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Vericel Corp's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Vericel Corp's value.| Shares | William Blair Investment Management, Llc | 2025-06-30 | 1.2 M | Federated Hermes Inc | 2025-06-30 | 1.1 M | Bnp Paribas Investment Partners Sa | 2025-06-30 | 1.1 M | Royal Bank Of Canada | 2025-06-30 | 1.1 M | Loomis, Sayles & Company Lp | 2025-06-30 | 1 M | Champlain Investment Partners, Llc | 2025-06-30 | 997.3 K | New York State Common Retirement Fund | 2025-06-30 | 890.5 K | Allspring Global Investments Holdings, Llc | 2025-06-30 | 859.5 K | Capital Research Global Investors | 2025-06-30 | 853.7 K | Blackrock Inc | 2025-06-30 | 7.6 M | Vanguard Group Inc | 2025-06-30 | 3.6 M |
Vericel Fundamentals
| Return On Equity | 0.0452 | ||||
| Return On Asset | 0.0105 | ||||
| Profit Margin | 0.05 % | ||||
| Operating Margin | 0.05 % | ||||
| Current Valuation | 1.81 B | ||||
| Shares Outstanding | 50.57 M | ||||
| Shares Owned By Insiders | 1.00 % | ||||
| Shares Owned By Institutions | 99.00 % | ||||
| Number Of Shares Shorted | 4.17 M | ||||
| Price To Earning | 357.33 X | ||||
| Price To Book | 5.75 X | ||||
| Price To Sales | 7.15 X | ||||
| Revenue | 237.22 M | ||||
| Gross Profit | 190.97 M | ||||
| EBITDA | 16.63 M | ||||
| Net Income | 10.36 M | ||||
| Cash And Equivalents | 100.69 M | ||||
| Cash Per Share | 2.13 X | ||||
| Total Debt | 98.85 M | ||||
| Debt To Equity | 0.28 % | ||||
| Current Ratio | 6.20 X | ||||
| Book Value Per Share | 6.37 X | ||||
| Cash Flow From Operations | 58.16 M | ||||
| Short Ratio | 7.07 X | ||||
| Earnings Per Share | 0.26 X | ||||
| Target Price | 55.0 | ||||
| Number Of Employees | 357 | ||||
| Beta | 1.18 | ||||
| Market Capitalization | 1.85 B | ||||
| Total Asset | 432.72 M | ||||
| Retained Earnings | (392.81 M) | ||||
| Working Capital | 162.49 M | ||||
| Current Asset | 21.1 M | ||||
| Current Liabilities | 15.36 M | ||||
| Net Asset | 432.72 M |
About Vericel Corp Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Vericel Corp Ord's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Vericel Corp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Vericel Corp Ord based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out Vericel Corp Piotroski F Score and Vericel Corp Altman Z Score analysis. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vericel Corp. If investors know Vericel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vericel Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.476 | Earnings Share 0.26 | Revenue Per Share | Quarterly Revenue Growth 0.166 | Return On Assets |
The market value of Vericel Corp Ord is measured differently than its book value, which is the value of Vericel that is recorded on the company's balance sheet. Investors also form their own opinion of Vericel Corp's value that differs from its market value or its book value, called intrinsic value, which is Vericel Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vericel Corp's market value can be influenced by many factors that don't directly affect Vericel Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vericel Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vericel Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vericel Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.